Pfizer-BioNTech COVID-19 vaccine Comirnaty receives full Health Canada approval for individuals 12 years and older

Pfizer

16 September 2021 - Health Canada Notice of Compliance is based on a comprehensive submission package including six month efficacy and safety data after second dose

Pfizer and BioNTech today announced that Health Canada has granted full approval (Notice of Compliance) for Comirnaty to prevent COVID-19 in individuals 12 years of age and older.

Read Pfizer press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , Canada , Vaccine , COVID-19